CA49937-3 - 0x000000000000699E

Males & Females of Non-Childbearing Potential

* Stipend may pay up to reflected amount.

Start Date:

February 15, 2026 - 2:00pm

End Date:

April 27, 2026 - 9:30am

Study Number: CA49937

Group Number: 3

Study Requirement: Healthy Normal Male and Female

Stipend: up to $6,750.00

Age: 19 - 55

BMI: 0 - 0

Weight Restriction: minimum weight 0 lbs

Indication: This investigational medication is being developed to treat inflammatory bowel disease.

Route of Administration: Injection IV infusion; Injection subcutaneous

Blood Draws: 16

Schedule Type: Short stays with returns

Study Length: 5 Night Stay & 4 Returns

Event Type	Start Day	Start Date	End Day	End Date	Phase	Site
Check-In	Sunday	2/15/2026 2:00:00 PM	Friday	2/20/2026 8:30:00 AM	1	Lincoln
Return	Monday	3/2/2026 7:20:00 AM	Monday	3/2/2026 8:30:00 AM	1	Lincoln
Return	Monday	3/16/2026 8:20:00 AM	Monday	3/16/2026 9:30:00 AM	1	Lincoln
Return	Monday	3/30/2026 8:20:00 AM	Monday	3/30/2026 9:30:00 AM	1	Lincoln
Return	Monday	4/27/2026 8:20:00 AM	Monday	4/27/2026 9:30:00 AM	1	Lincoln